Suchergebnisse - "Iwanami, Shoya"

PubPharm (9)

1

A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19

enthalten in: Microbiology spectrum | 2023

von Miyazaki, T. | Hosogaya, N. | Fukushige, Y. | +36

2

Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors

enthalten in: Journal of theoretical biology | 2023

von Tatematsu, D. | Akao, M. | Park, H. | +3

3

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data : mathematical modelling study

enthalten in: BMC infectious diseases | 2022

von Ejima, K. | Kim, K. | Bento, A. | +5

4

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study

enthalten in: BMC infectious diseases | 2022

von Ejima, K. | Kim, K. | Bento, A. | +5

5

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study

enthalten in: BMC infectious diseases | 2022

von Ejima, K. | Kim, K. | Bento, A. | +5

6

Revisiting the guidelines for ending isolation for COVID-19 patients

enthalten in: eLife | 2021

von Jeong, Y. | Ejima, K. | Kim, K. | +10

7

Estimation of the incubation period of COVID-19 using viral load data

enthalten in: Epidemics | 2021

von Ejima, K. | Kim, K. | Ludema, C. | +9

8

Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model

enthalten in: Journal of the Royal Society, Interface | 2021

von Ejima, K. | Kim, K. | Iwanami, S. | +7

9

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

enthalten in: Frontiers in microbiology | 2021

von Shionoya, K. | Yamasaki, M. | Iwanami, S. | +14

1
[1]